An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

The Apicoplast--A Target for Parasiticidal Chemotherapy

Crawford, Michael
University of Pennsylvania
Start date
End date
The objectives of this proposal are to test this hypothesis, by: (1) Examining the kinetics of death observed in rifamycin antibiotics (thought to inhibit the plastid-encoded RNA polymerase), and developing T. gondii mutants resistant to rifamycins. (2) Identifying and characterizing nuclear-encoded plastid topoisomerases (the probable target of fluoroquinolone antibiotics), using a combination of bioinformatic, biochemical, and genetic approaches.
More information
The phylum Apicomplexa includes many human pathogens, such as Plasmodium (the causative agent of malaria), Toxoplasma and Cryptosporidium (important opportunistic parasites associated with AIDS). Widespread drug-resistance and the poor tolerance of treatments available have lent new urgency to the development of novel chemotherapeutic strategies for these parasites. The discovery that these organisms harbor a plastid which is essential for their survival has therefore produced considerable interest. Several antibiotics that are normally effective only against prokaryotic organisms (including macrolides and fluoroquinolones) exhibit activity against Toxoplasma gondii and other apicomplexans, and several lines of argument suggest that these compounds target apicoplast functions.
Funding Source
Nat'l. Inst. of Allergy and Infectious Diseases
Project number